hCas9-VPR Citations (2)
Originally described in: Cas9 gRNA engineering for genome editing, activation and repression.Kiani S, Chavez A, Tuttle M, Hall RN, Chari R, Ter-Ovanesyan D, Qian J, Pruitt BW, Beal J, Vora S, Buchthal J, Kowal EJ, Ebrahimkhani MR, Collins JJ, Weiss R, Church G Nat Methods. 2015 Sep 7. doi: 10.1038/nmeth.3580. PubMed Journal
Articles Citing hCas9-VPR
| Articles |
|---|
Multiplexed orthogonal genome editing and transcriptional activation by Cas12a.
Breinig M, Schweitzer AY, Herianto AM, Revia S, Schaefer L, Wendler L, Cobos Galvez A, Tschaharganeh DF.
Nat Methods. 2019 Jan;16(1):51-54. doi: 10.1038/s41592-018-0262-1. Epub 2018 Dec 17.
PubMed
Associated Plasmids |
| CRISPR-Cpf1 Activation of Endogenous BMP4 Gene for Osteogenic Differentiation of Umbilical-Cord-Derived Mesenchymal Stem Cells. Choi J, Bae T, Byambasuren N, Park SH, Jo CH, Kim D, Hur JK, Hwang NS. Mol Ther Methods Clin Dev. 2020 Jan 9;17:309-316. doi: 10.1016/j.omtm.2019.12.010. eCollection 2020 Jun 12. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.